Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (371-380 of 520) with videos related to

Pageof 52
Sort By:
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Leukemia & Lymphoma|June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approachOscar B Lahoud, Heather Landau, James Nguyen, et al.
Plos One|November 2, 2018
Dietary intake is associated with risk of multiple myeloma and its precursor diseaseMarianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
JNCI Cancer Spectrum|December 18, 2020
A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its PrecursorJonathan N Hofmann, Ola Landgren, Rebecca Landy, et al.
JAMA|December 15, 2011
Cancer risk among patients with myotonic muscular dystrophyShahinaz M Gadalla, Marie Lund, Ruth M Pfeiffer, et al.
Blood Cancer Journal|February 2, 2025
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclaxCaroline A Coughlin, Dhanvantri Chahar, Marianna Lekakis, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2018
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsMaria E Arcila, Wayne Yu, Mustafa Syed, et al.
Blood Cancer Journal|August 22, 2022
Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disasterRachel Zeig-Owens, David G Goldfarb, Benjamin J Luft, et al.
Blood|October 31, 2008
Solid cancers after allogeneic hematopoietic cell transplantationJ Douglas Rizzo, Rochelle E Curtis, Gérard Socié, et al.
Pageof 52

Showing results (371-380 of 520) with videos related to

Sort By:
Pageof 52
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Leukemia & Lymphoma|June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approachOscar B Lahoud, Heather Landau, James Nguyen, et al.
Plos One|November 2, 2018
Dietary intake is associated with risk of multiple myeloma and its precursor diseaseMarianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
JNCI Cancer Spectrum|December 18, 2020
A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its PrecursorJonathan N Hofmann, Ola Landgren, Rebecca Landy, et al.
JAMA|December 15, 2011
Cancer risk among patients with myotonic muscular dystrophyShahinaz M Gadalla, Marie Lund, Ruth M Pfeiffer, et al.
Blood Cancer Journal|February 2, 2025
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclaxCaroline A Coughlin, Dhanvantri Chahar, Marianna Lekakis, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2018
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsMaria E Arcila, Wayne Yu, Mustafa Syed, et al.
Blood Cancer Journal|August 22, 2022
Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disasterRachel Zeig-Owens, David G Goldfarb, Benjamin J Luft, et al.
Blood|October 31, 2008
Solid cancers after allogeneic hematopoietic cell transplantationJ Douglas Rizzo, Rochelle E Curtis, Gérard Socié, et al.
Pageof 52